Skip to main content
padlock icon - secure page this page is secure

Soluble Epoxide Hydrolase, a Target with Multiple Opportunities for Cardiovascular Drug Discovery

Buy Article:

$68.00 + tax (Refund Policy)

Soluble epoxide hydrolase (sEH) is a cross-functional target, with the potential for therapeutic utility in the areas of hypertension, inflammation, and organ-protection [1]. Promising target validation has emerged around soluble epoxide hydrolase in recent years which suggests that small molecule inhibitors may have utility in cardio protection, glucose regulation, hypertension, inflammation, and organ protection. Based on the diversity of chemical classes of sEH inhibitors reported in the literature, there exists a real opportunity to definitively determine the best therapeutic utility for an sEH inhibitor. Recent advances in target validation and tool compounds from medicinal chemistry efforts will be described.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: DHETs; EETs; Ephx2; P450 monooxygenase; Soluble epoxide hydrolase; dihydroxyeicosatrienoic acids; epoxyeicosatrienoic acids

Document Type: Research Article

Affiliations: Metabolic Pathways Center of Excellence in Drug Discovery, Glaxo-SmithKline Research and Development, 709 Swedeland Rd., King of Prussia, PA 19406, USA.

Publication date: April 1, 2009

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more